2024. Cutaneous Drug Reaction Due to Bortezomib Characterized by Erythematous Reticular Plaques in a Patient With Multiple Myeloma. Dermatology Practical & Conceptual. 14, 4 (Oct. 2024), e2024243. DOI:https://doi.org/10.5826/dpc.1404a243.